Abstract:This study investigated the effects of microRNA-135a (miR-135a) targeting of glycogen synthase kinase 3β (GSK3β) on the epithelial–mesenchymal transition (EMT), migration and invasion of bladder cancer (BC) cells by mediating the Wnt/β-catenin signaling pathway. BC and adjacent normal tissues were collected from 165 BC patients. Western blotting and quantitative real-time PCR were used to detect the expression of GSK3β, β-catenin, cyclinD1, E-cadherin, vimentin and miR-135a in BC tissues and cells. Cells were assigned to blank, negative control (NC), miR-135a mimics, miR-135a inhibitors, small interfering RNA (siRNA)-GSK3β or miR-135a inhibitors+siRNA-GSK3β groups. miR-135a, β-catenin, cyclinD1 and vimentin expression increased, while GSK3β and E-cadherin expression decreased in BC tissues compared with adjacent normal tissues. Compared with the blank and NC groups, the expression of miR-135a, β-catenin, cyclinD1 and vimentin was higher, and cell proliferation, migration, invasion and tumor growth were increased in the miR-135a mimics and siRNA-GSK3β groups. These groups showed an opposite trend in GSK3β and E-cadherin expression and cell apoptosis. The miR-135a inhibitors group was inversely correlated with the blank and NC groups. It was concluded that miR-135a accelerates the EMT, invasion and migration of BC cells by activating the Wnt/β-catenin signaling pathway through the downregulation of GSK3β expression. The small regulatory RNA molecule microRNA-135a contributes to bladder cancer by stimulating cell proliferation and migration. Dr Nan Zhang and colleagues at Zhejiang University Medical College in Hangzhou, China, examined both bladder cancer and adjacent normal tissues in 156 patients. The levels of microRNA-135a and of the signaling protein β-catenin were higher in the cancerous tissue. In contrast, the levels of the tumor suppressor glycogen synthase kinase-3 beta (GSK-3β) were lower, suggesting that micro-RNA135a triggers signaling through the Wnt/β-catenin pathway. This evolutionarily conserved pathway is crucial for orchestrating development and when deregulated can lead to diseases including cancer and osteoporosis. Increased expression of micro-RNA135a stimulated cell proliferation and motility in human bladder cells and tumor growth in mice through this signaling pathway. These findings could lead to new treatment strategies for bladder cancer patients.

MicroRNA-137 regulates hypoxia-mediated migration and epithelial-mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway

Mir-145 Suppresses Breast Cancer Cell Migration by Targeting FSCN-1 and Inhibiting Epithelial-Mesenchymal Transition.

MicroRNA-141 Inhibits Migration of Gastric Cancer by Targeting Zinc Finger E-box-binding Homeobox 2

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines.

Downregulated NOX4 underlies a novel inhibitory role of microRNA‐137 in prostate cancer

microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.

miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells

Low Expression of Microrna-30C Promotes Prostate Cancer Cells Invasion Involved in Downregulation of KRAS Protein.

Mir-154 Inhibits EMT by Targeting HMGA2 in Prostate Cancer Cells

Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells

Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1

MicroRNA-195-5p, a New Regulator of Fra-1, Suppresses the Migration and Invasion of Prostate Cancer Cells

MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance

Effects of Microrna-135A on the Epithelial–mesenchymal Transition, Migration and Invasion of Bladder Cancer Cells by Targeting GSK3β Through the Wnt/β-catenin Signaling Pathway

Mir-186-5p Promotes Cell Growth, Migration and Invasion of Lung Adenocarcinoma by Targeting PTEN

miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer